Fact Meets Function

The development of small molecule angiotensin IV analogs to treat Alzheimer’s and Parkinson’s diseases.

This review article examines the development of small molecule analogs of angiotensin IV, particularly dihexa, as potential therapeutic agents for neurodegenerative diseases including Alzheimer’s and Parkinson’s disease, synthesizing evidence from preclinical research on mechanisms of neuroprotection and cognitive enhancement. The review discusses how these analogs may work through the AT4 receptor pathway to promote neuroplasticity and reduce neuroinflammation, drawing on findings from animal models and in vitro studies, though clinical evidence in human subjects remains limited.

**Evidence level:** Review article synthesizing animal model and in vitro research

The development of small molecule angiotensin IV analogs to treat Alzheimer’s and Parkinson’s diseases. Read Post »

Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.

This prospective, randomized, controlled study evaluated ipamorelin, a ghrelin mimetic, as a treatment for postoperative ileus in patients undergoing bowel resection. The research assessed whether ipamorelin could improve recovery of bowel function following surgery in this patient population. This evidence comes from a human clinical trial.

Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Read Post »

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system.

This preclinical study (in vitro and animal model evidence) investigated how angiotensin IV-derived peptides, specifically dihexa, enhance cognitive function and synapse formation, finding that these effects depend on activation of the hepatocyte growth factor (HGF)/c-met signaling pathway. Researchers demonstrated that blocking the HGF/c-met system prevented the cognitive and synaptogenic benefits typically observed with these peptides in their experimental models. The findings suggest that the HGF/c-met pathway is a critical mechanism underlying the procognitive effects of angiotensin IV-derived peptides.

The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. Read Post »

Effects of topical copper tripeptide complex on wound healing in an irradiated rat model.

This animal model study examined how a topical copper tripeptide complex (GHK-Cu) affected wound healing in rats that had been exposed to radiation. The research found that the copper tripeptide complex demonstrated beneficial effects on wound healing parameters in the irradiated rat model. This is an animal model study with limited direct applicability to human clinical practice.

Effects of topical copper tripeptide complex on wound healing in an irradiated rat model. Read Post »

Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia.

Researchers analyzed serum peptide profiles in pregnant women to identify peptide biomarkers that could distinguish preeclampsia cases from normal pregnancies, utilizing peptidomic techniques to characterize protein fragments circulating in blood samples. The study identified specific peptide signatures, including TB4-Fragment, that showed potential diagnostic value for preeclampsia detection. This evidence comes from human clinical studies analyzing biomarker patterns in patient serum samples.

Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia. Read Post »

alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.

This animal model study examined alpha-melanocyte-stimulating hormone (alpha-MSH) related peptides, including KPV, as potential anti-inflammatory and immunomodulating agents for treating rheumatic diseases. The research found that these peptides demonstrated anti-inflammatory properties and immunomodulatory effects in animal systems, suggesting a novel therapeutic class for conditions like rheumatoid arthritis. This evidence is derived from animal model research and represents an early stage of investigation prior to human clinical application.

alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Read Post »

Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits.

Research Summary

This preclinical study evaluated wound healing in rabbits treated with topical tripeptide-copper complex (GHK-Cu) and zinc oxide applied to open wounds. The researchers assessed healing outcomes and compared the effects of these two topical agents in an animal model. The evidence level is animal model (rabbit wounds).

Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits. Read Post »

Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide.

This human clinical study examined how the tripeptide KPV (the C-terminal portion of alpha-melanocyte-stimulating hormone) affects corneal epithelial wound healing and the role of nitric oxide in this process. The research investigated the mechanisms by which KPV influences corneal epithelial cell repair, with particular focus on nitric oxide signaling pathways. This human clinical evidence provides direct data on KPV’s effects on corneal wound healing in human subjects.

Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Read Post »

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

This human clinical study examined whether pulsatile growth hormone secretion patterns persist when using CJC-1295, a long-acting growth hormone-releasing hormone analog, administered as continuous stimulation. The researchers found that pulsatile GH secretion was maintained despite the continuous nature of CJC-1295 stimulation, demonstrating that the body’s natural rhythmic GH release pattern is preserved with this compound. This evidence comes from a human clinical trial design.

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Read Post »

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

This human clinical study examined CJC-1295, a long-acting GH-releasing hormone analog, and found that it stimulated prolonged secretion of growth hormone and insulin-like growth factor I in healthy adult subjects. The extended duration of hormone elevation distinguishes this compound from shorter-acting GH-releasing hormone preparations. This evidence comes from direct human clinical investigation.

Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Read Post »

Methylene Blue

An older study found that methylene blue did not discolor breast milk when given to nursing mothers, suggesting it may not pass into milk since the drug is 94% protein bound. However, current safety guidelines still recommend stopping breastfeeding during treatment and for 8 days after based on the drug’s 24-hour half-life. There is no available safety data specifically for oral methylene blue use during breastfeeding.

Methylene Blue Read Post »

Scroll to Top